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Abstract
We performed a case-control association analysis of rheumatoid arthritis (RA) for several
candidate genes using the North American Rheumatoid Arthritis Consortium (NARAC) data
provided in Genetic Analysis Workshop 15. We conducted the case-control association analysis
using all related cases and unrelated controls and compared the results with those from the analysis
of samples using only one randomly selected case from each family and all unrelated controls. For
both analyses we used a weighted composite likelihood ratio test based on single-nucleotide
polymorphism (SNP) markers or haplotypes accounting for the correlation among samples within
a family. Several SNPs, including R620W in the candidate gene PTPN22, showed an association with
RA status, which confirmed previously reported results. Several other SNPs in the candidate genes,
such as CTLA4,  HAVCR1, and SUMO4, also had rather small p-values (<0.05), suggesting the
associations between them and RA. Our results showed that the p-values obtained from the
analysis including all related cases were generally smaller than those obtained from the analysis
including only one randomly selected case per family. These results, together with the results,
based on simulated data, showed that higher power could be achieved using all related cases.
Background
Case-control studies using unrelated case and control
samples provide a powerful and efficient way to assess the
association between candidate genes and diseases. How-
ever, case-control studies with related case samples are not
uncommon, especially for follow-up studies from a link-
age study using pedigrees and/or affected sib pairs. The
association analysis based on related cases can be more
effective than that based on unrelated cases randomly
selected from the population [1] because having more
affected members in families will increase the difference
in risk allele frequencies between cases and controls [2].
When related cases are available, a simple method for
conducting a case-control analysis is to select one case
from each family randomly. Although this method is ana-
lytically simple, it results in lower power compared with
methods that include all related case samples. On the
other hand, the use of all related cases without appropri-
ately accounting for their correlations will result in
inflated type I error rates. Therefore, many methods were
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developed to account for the correlation among related
cases [1-4]. Browning et al. [3] proposed a weighted com-
posite likelihood ratio test in which the weights of sam-
ples are calculated according to their kinship coefficients.
One advantage of this method is that it is applicable to
both single markers and haplotypes. In this study, we per-
formed an association analysis of rheumatoid arthritis
(RA) status with two candidate gene data sets of related
cases and unrelated controls from the North American
Rheumatoid Arthritis Consortium (NARAC) data pro-
vided in Genetic Analysis Workshop 15. We applied the
method developed by Browning et al. [3] to these data sets
and compared the p-values with those obtained from the
analysis including only one randomly selected case from
each family. We also assessed how the exclusion of candi-
date variants can affect the analysis and performed the
analysis based on multiple markers and haplotypes to
identify the effect of multiple single-nucleotide polymor-
phisms (SNPs).
Methods
Weighted composite likelihood ratio test using kinship 
coefficients
Here, we briefly introduce the weighted composite likeli-
hood ratio (WCLR) test developed by Browning et al. [3].
Denote the individual i's genotype at a single marker as
 for i = 1, 2,...,n, where   and   are one
of the alleles A1,...,Al with the corresponding frequency
. The weight of each individual is denoted as wi.
A weighted composite likelihood of a single marker is
then ,  where  p  = ( ).
Based on this composite likelihood, the allele frequency
can be estimated for only cases ( ), only controls ( ),
and all cases and controls ( ). A likelihood ratio test can
be constructed as   and it asymptotically
follows a chi-square distribution with l - 1 degrees of free-
dom. Similarly, the likelihood ratio test based on haplo-
types and a given set of weights can also be constructed. In
general, haplotypes for samples are unknown. In this sit-
uation, the haplotype frequencies can be estimated via the
expectation-maximization (EM) algorithm and incorpo-
rated into the test.
The weight wi of each individual is calculated based on
their kinship coefficients. Specifically, w = (w1,...,wn) satis-
fies 2(w1,...,wn)K = (1,...,1), where K is the n × n kinship
matrix. The sum of weights, w1 + ... + wn, can be considered
as the effective sample size, which is greater than the
number of families but less than the total number of sam-
ples. Thus, we expect the power of this method to be
greater than that of the method using one randomly
selected case per family. Finally, it is worth noting that wi
= 1 for unrelated individuals. In this situation, the
weighted composite likelihood becomes the ordinary
likelihood.
Candidate gene analysis
We analyzed two candidate gene data sets from NARAC
using CCREL software that implements the WCLR test of
Browning et al. [3]. The first data set contains genotypes of
1256 cases from 665 nuclear families and 1519 unrelated
controls at 14 SNP markers in the candidate gene PTPN22
[5]. The 14 SNPs are labeled as SNP1 to SNP14 corre-
sponding to their positional order along chromosome 1.
One family was excluded from the analysis because of
genotyping errors. Most of the parents' genotypes were
not available. The second data set contains genotypes of
816 cases from 461 nuclear families and 855 unrelated
controls at 20 SNP markers in 14 candidate genes, includ-
ing PTPN22, CTLA4, TNFRSF1B, PADI4, HAVCR1, IBD5,
SLC22A4, IL3, IL4, SUMO4, ILG5, CARD15, RUNX1, and
MFL [6]. We performed the case-control association anal-
ysis using two methods. In the first method we used all
cases and controls and applied the WCLR test. In the sec-
ond method, we randomly selected one case from each
family and included all unrelated controls and applied the
allelic chi-square test. For the first data set, we performed
the single marker analysis, the multiple marker analysis
(the stepwise logistic regression), and the haplotype anal-
ysis on two or three markers. We also obtained the linkage
disequilibrium (LD) measure (r2) between SNPs from this
data set. For the second data set, we performed the single-
marker analysis because this data set only includes a few
SNPs for each candidate gene.
Power comparison
The power of the two methods based on all related cases
and all controls, the weighted composite likelihood ratio
test [3] and the method suggested by Slager and Schaid
[1], and the power of the method using only one ran-
domly selected case per family and all controls were eval-
uated and compared based on simulated data. One
thousand data sets were generated and each of them con-
sisted of 200 affected sib pairs (400 cases) and 200 unre-
lated controls. Only genotypes at the disease locus were
simulated and analyzed. The minor allele frequencies at
the disease locus for cases and controls were set as 0.141
and 0.095 to calculate the power, and set as 0.10 and 0.10
to calculate the type I error rate. The significance level was
set as 0.05.
Results
Association of RA status with PTPN22
Table 1 shows the results of the single-marker analysis
using all cases and controls and using one randomly
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selected case per family and all controls for each SNP of
PTPN22 provided in the first data set. The minor allele fre-
quencies at each marker locus were estimated separately
for cases and controls. SNP3, SNP5, SNP7, SNP9, SNP13,
and SNP14 had p-values less than 0.05 for both methods.
For SNP6, SNP10, and SNP12, the analysis including all
cases yielded p-values less than 0.05 but the analysis
including one randomly selected case did not. SNP9
(R620W) showed the strongest association among all 14
SNPs using both methods. Most of the p-values for the
analysis including all related cases were smaller than
those for the analysis including one randomly selected
case per family.
Using the data of one randomly selected case per family,
we performed a stepwise logistic regression to see whether
the association with SNP9 in PTPN22 accounted for the
associations were observed with other SNPs. Six SNPs,
SNP2, SNP4, SNP8, SNP9, SNP11, and SNP14 were
included in the final model according to the Akaike Infor-
mation Criterion (AIC). Among them, SNP2, SNP4,
SNP8, and SNP11 did not show the associations with RA
status in the single-marker analysis, suggesting the exist-
ence of the epistatic effect between them. SNP3, SNP5,
SNP7, and SNP13 were in moderate LD with SNP9 and
were not included in the final model, indicating that the
associations observed with these SNPs were accounted for
by SNP9.
We excluded SNP9, which was reported to have the
strongest association with RA status, from the haplotype
analysis to see whether the haplotypes of other SNPs
could capture its effect. We first performed the haplotype
analysis based on sliding windows with two or three
SNPs. Several haplotypes showed the associations with RA
status but haplotypes formed by two SNPs closest to SNP9
(SNP8 and SNP10, both were in low LD with SNP9) did
not. We then performed the haplotype analysis for five
SNPs in the stepwise logistic regression model (SNP2,
SNP4, SNP8, SNP11, SNP14) and found several haplo-
types that showed significant associations with RA status
(Table 2). We also performed the haplotype analysis for 3
SNPs that showed moderate LD (r2:0.3~0.5) with SNP9
(SNP3, SNP5, SNP13) and found that all haplotypes
showed significant associations with RA status (Table 2).
In the haplotype analysis, most of the p-values for the
analysis including all cases were smaller than those for the
analysis including one randomly selected case per family.
Association of RA status with other candidate genes
Table 3 shows the significant results of the single-marker
analysis for 20 SNPs in 14 candidate genes for both meth-
ods. As expected, PTPN22 showed the strongest associa-
tion with RA status. Also, all SNPs in candidate gene
CTLA4, HAVCR1, and SUMO4 had p-values less then 0.05
for the analysis including all cases but some of these p-val-
ues were not significant for the analysis including one ran-
domly selected case per family.
Table 1: Single-marker analysis for SNPs in PTPN22
Minor Allele Frequencies p-valuesa
Cases Controls
SNP dbSNP ID Affected Siblingb 
(n = 1256)
One Sibling per Familyc 
(n = 664)
(n = 1519) Affected Siblingb One Sibling per Familyc
1 rs3789604 0.198 0.199 0.179 0.10251 0.11214
2d rs3811021 0.199 0.200 0.179 0.0978 0.10504
3 rs1217413 0.269 0.267 0.217 7 × 10-5 0.00039
4d Ss38346942 0.015 0.015 0.013 0.68537 0.63067
5 rs1217388 0.292 0.293 0.251 0.00233 0.00436
6 Ss38346943 0.017 0.020 0.027 0.03122 0.13409
7 rs1310182 0.491 0.495 0.430 5 × 10-5 7 × 10-5
8d Ss38346944 0.03 0.031 0.023 0.19819 0.15854
9d rs2476601 0.154 0.160 0.084 4.32 × 10-13 8.53 × 10-13
10 rs12730735 0.268 0.270 0.295 0.04785 0.09262
11d rs11102685 0.091 0.085 0.076 0.0629 0.32266
12 rs12760457 0.267 0.269 0.294 0.04884 0.09406
13 rs2488458 0.292 0.293 0.252 0.00257 0.00472
14d rs1217414 0.243 0.236 0.276 0.01283 0.00526
ap-Values were not adjusted for the multiple testing.
bAllele frequencies and p-values were obtained using all cases and unrelated controls.
cAllele frequencies and p-values obtained using one randomly selected case per family and unrelated controls.
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Power comparison
Our simulation results showed that the weighted compos-
ite likelihood ratio test [3] had a power of 89.4%, which
was very similar to the power of the method developed by
Slager and Schaid [1] (89.2%). Both of them had higher
power than the method using one randomly selected case
per affected sib pair and all unrelated controls (79.0%).
All three methods showed appropriate type I error rates
close to the nominal level of 0.05 (0.047, 0.048, and
0.053, respectively).
Discussion
Carlton et al. [5] conducted the case-control association
analysis using a subset of the first data set of 14 PTPN22
SNPs by randomly selecting one affected case from each
family. Their reported p-values based on single markers
are slightly different from our results for SNP10, SNP11,
and SNP12, which might be due to the random selection
of the set of case samples. Most of SNPs in the second data
set were analyzed by Plenge et al. [6], and our results over-
all are consistent with their findings. Our results, obtained
by randomly selecting one case from each family, varied
from one selection to another. In practice, there are no
guidelines for choosing the best result because the results
generally reflect the selection process.
The results from the stepwise logistic regression analysis
showed that the effect of several SNPs disappeared when
SNP9 was included in the analysis. These SNP were in
moderate LD with SNP9 and showed the associations
with RA status in the single marker analysis, indicating
their associations with RA status may be mainly due to the
association of SNP9 with RA status. Several SNPs that
were included in the final regression model did not show
the associations in the single marker analysis but showed
the associations in the haplotype analysis (e.g., SNP2 and
SNP11). SNP2 and SNP1 (strong LD with SNP2, r2 =
0.997) have been suggested as having the associations
with RA status by Carlton et al. [5].
We also performed haplotype analysis based on two or
three SNPs after excluding SNP9 from the PTPN22 SNP
data set. We wanted to see whether the indirect associa-
tion between RA and these SNPs could be better captured
using haplotype analysis. The two SNPs adjacent to SNP9,
SNP8 and SNP10, did not show an association with RA in
the haplotype analysis; SNP8 showed no association with
RA, and SNP10 showed only marginal association with
RA in the single-marker analysis. However, haplotypes
based on SNPs in moderate LD with SNP9 showed associ-
ations with RA status. Thus, the sliding-window approach
Table 3: Single-SNP case-control analysis for SNPs in 14 candidate genes
Minor Allele Frequencies p-valuesa
Cases Controls
Gene dbSNP ID Affected Siblingb 
(n = 816)
One Sibling per Familyc
 (n = 461)
(n = 855) Affected Siblingb One Sibling per Familyc
PTPN22 Rs2476601 0.163 0.156 0.084 2.13 × 10-10 4.96 × 10-8
CTLA4 Rs3087243 0.447 0.407 0.447 0.01016 0.04618
HAVCR1 Rs6149307 0.17 0.174 0.142 0.03939 0.03193
HAVCR1 5509_5511 delCAA 0.195 0.200 0.235 0.01834 0.05172
SUMO4 Rs237025 0.517 0.520 0.456 0.00154 0.00202
SUMO4 Rs577001 0.391 0.387 0.350 0.02512 0.06162
ap-Values were not adjusted for the multiple testing. Only significant results are presented in the table.
bAllele frequencies and p-values were obtained using all cases and unrelated controls.
cAllele frequencies and p-values were obtained using one randomly selected case per family and unrelated controls.
Table 2: Haplotype analysis for SNPs in PTPN22
SNPs selected in the stepwise regression 
(SNP2, SNP4, SNP8, SNP11, SNP14)
SNPs in LD with SNP9 
(SNP3, SNP5, SNP13)
Combinations p-valuesa Combinations p-valuesa
2 & 11 0.008 3 & 5 0.0001
2 & 4 & 11 0.016 3 & 13 0.0001
2 & 8 & 11 0.013 5 & 13 0.009
2 & 11 & 14 0.0003 3 & 5 & 13 0.0002
ap-Values were obtained using all cases and unrelated controls and were not adjusted for the multiple testing.Publish with BioMed Central    and   every 
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may not be sufficient to capture the associations for
untyped SNPs. In this situation, one can analyze haplo-
types based on all combinations of several SNPs but with
rapidly increased number of tests. One can also only ana-
lyze haplotypes in high LD with untyped SNPs with
reduced number of tests, if the LD patterns can be
obtained from publicly available data resources (e.g.,
HapMap project).
Conclusion
We analyzed the association between several candidate
genes and RA status using all related cases and all unre-
lated controls. Our analysis showed that several SNPs in
the candidate gene PTPN22 were significantly associated
with RA status with possible epistatic effects. Also, SNPs in
CTLA4, HAVCR1, and SUMO4 were significantly associ-
ated with RA status.
We compared the results of the analysis including all
related cases with those of the analysis including only one
randomly selected case per family. The p-values from the
analysis including all cases were generally smaller than
those from the analysis including only one randomly
selected case per family, suggesting the higher power of
the method using all cases. This was confirmed by the
power comparison based on simulated data. Thus, we
suggest the use of methods that can use all related cases
and can correctly account for the correlations among
them, such as the weighted composite likelihood method
of Browning et al. [3], rather than the methods that use
one randomly selected case per family, in order to yield
more power and eliminate inconsistency.
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